Skip to main content

Table 3 P-values for the pairwise comparisons of the level of prehension, total consumption, useful consumption and refusal for each product

From: Comparative palatability of five supplements designed for cats suffering from chronic renal disease

Product comparisons

Prehension

Total consumption

Useful consumption

Refusal

Ipakitine vs Renalzin

0.6293

1.0000

0.0005*

0.3383

Ipakitine vs Azodyl

0.9207

0.0011*

<.0001*

0.7038

Ipakitine vs Rubenal

0.1450

0.0786

0.0118*

0.0076

Ipakitine vs Pronefra

0.0023*

<.0001*

<.0001*

<.0001*

Renalzin vs Azodil

0.7039

0.0011*

0.0336*

0.1838

Renalzin vs Rubenal

0.3176

0.0786

0.2906

0.0784

Renalzin vs Pronefra

0.0008*

<.0001*

<.0001*

<.0001*

Azodyl vs Rubenal

0.1758

0.0900

0.0022*

0.0026*

Azodyl vs Pronefra

0.0019*

0.1088

0.0459*

0.0002*

Rubenal vs Pronefra

<.0001*

0.0013*

<.0001*

<.0001*

  1. Where products are significantly different, this is noted in bold with an asterisk.
Back to article page

Irish Veterinary Journal

ISSN: 2046-0481